ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

How Techceuticals, PharmParts, and smart auction strategies are ushering in a new era of efficiency and innovation for CDMOs ...

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

The ERVI is reviewing the EU's production capacity for metallic HALEU. It is also looking at ways to enhance the production ...

The new lab will be used to develop and scale innovations for the production of medicines and to help secure the supply chain ...

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

The grant encompasses $100,000 each from the Life Sciences Entrepreneurship Center and Berkeley SkyDeck, with SkyDeck having ...

Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance ...

Global scale-up requires developing replicable processes that work the same no matter where they are performed. This can be ...

Scientific breakthroughs, operational innovation, and cultural shifts are driving tomorrow’s medicines.

Pharmaceutical Technology® spoke with Martin Meeson, CEO of Axplora, about the role contract development and manufacturing ...